<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Mito Laboratories — Philosophy</title>
  <meta name="description" content="Platform science at Mito Laboratories: mitochondria-centric oncology, high-throughput screening, and protocolised program development." />
  <link rel="stylesheet" href="styles.css" />
</head>
<body>
<a class="skip-link" href="#main">Skip to content</a>
<header class="site-header">
  <div class="nav-shell">
    <a class="brand" href="index.html">
      <div class="brand-mark" aria-hidden="true"></div>
      <div class="brand-name">
        <strong>MITO LABORATORIES</strong>
        <span>Protocolised mitochondrial biology</span>
      </div>
    </a>

    <button class="nav-toggle" type="button" data-nav-toggle aria-expanded="false" aria-controls="primary-nav">
      Menu
    </button>

    <nav id="primary-nav" class="nav-links" data-nav-links aria-label="Primary navigation">
      <a class="nav-link" href="index.html">Home</a>

      <!-- Our Company dropdown (hover) -->
      <div class="nav-item has-dropdown">
        <a class="nav-link" href="company-about.html">
          Our Company <span class="chev" aria-hidden="true"></span>
        </a>

        <div class="dropdown" id="company-menu" role="menu" aria-label="Our Company">
          <a class="dropdown-link" role="menuitem" href="company-about.html" aria-current="page">About us</a>
          <a class="dropdown-link" role="menuitem" href="company-team.html">Meet our team</a>
          <a class="dropdown-link" role="menuitem" href="company-news.html">News &amp; Events</a>
        </div>
      </div>

      <!-- Science dropdown (hover) -->
      <div class="nav-item has-dropdown">
        <a class="nav-link" href="science.html">
          Science <span class="chev" aria-hidden="true"></span>
        </a>

        <div class="dropdown" role="menu" aria-label="Science">
          <a class="dropdown-link" role="menuitem" href="pipeline.html">Pipeline</a>
          <a class="dropdown-link" role="menuitem" href="science.html">Philosophy</a>
          <a class="dropdown-link" role="menuitem" href="disease-focus.html">Disease focus</a>
        </div>
      </div>

      <a class="nav-link nav-cta" href="mailto:info@mitolaboratories.com">Contact</a>
    </nav>
  </div>
</header>

<main id="main">
  <section class="hero">
    <div class="container hero-grid">
      <div>
        <div class="kicker"><b>Science</b> · mitochondria-centric oncology</div>
        <h1>High-throughput discovery for under-explored mitochondrial targets.</h1>
        <p>
          We combine a mitochondria-centric view of cancer biology with high-throughput screening to identify
          small-molecule candidates for molecular targets that are often technically challenging or under-prioritised.
          Programs are advanced using a protocolised, measurement-first development approach.
        </p>
        <div class="btn-row">
          <a class="btn primary" href="pipeline.html">View pipeline</a>
          <a class="btn" href="disease-focus.html">Disease focus</a>
        </div>
      </div>

      <aside class="hero-card" aria-label="Platform overview">
        <div class="hero-img" style="background-image:url('assets/hero-science.svg')"></div>
        <div class="hero-meta">
          <h3 style="margin:0 0 8px;font-size:16px;">Platform workflow</h3>
          <ul class="list">
            <li>Target logic → assay design</li>
            <li>HTS → hit confirmation</li>
            <li>Optimisation → translational readouts</li>
            <li>Protocolised clinical plan</li>
          </ul>
        </div>
      </aside>
    </div>
  </section>

  <section class="section">
    <div class="container">
      <h2>Platform thesis</h2>
      <p>
        Cancer cells frequently adapt their metabolism to survive stress, evade immune pressure, and persist under therapy.
        Because mitochondria sit at the centre of energy production, redox balance, apoptosis signalling, and biosynthetic
        flux, mitochondrial control points can act as high-leverage determinants of tumour behaviour and treatment response.
      </p>

      <p>
        Our scientific focus is not “one target, one drug, one disease.” Instead, we build programs around measurable
        mitochondrial and metabolic states — then develop small-molecule approaches to modulate them with clarity and discipline.
      </p>

      <div class="grid-3">
        <div class="card">
          <h3>Mitochondrial control points</h3>
          <p>Bioenergetics, redox, apoptotic priming, and stress signalling as program-defining levers.</p>
        </div>
        <div class="card">
          <h3>Small-molecule first</h3>
          <p>Preference for tractable, optimisable chemistry with intracellular access and measurable PK/PD paths.</p>
        </div>
        <div class="card">
          <h3>Measurement-first execution</h3>
          <p>Assays and biomarkers built early, so programs advance on data rather than narrative.</p>
        </div>
      </div>

      <hr class="hr" />

      <h2>High-throughput screening and hit discovery</h2>
      <p>
        We use high-throughput screening to identify small-molecule starting points against mitochondrial and metabolic targets
        that can be overlooked for strategic, technical, or historical reasons. Our goal is to turn strong mechanistic logic into
        actionable chemistry by building assays that report on function — not just binding.
      </p>

      <div class="grid-3">
        <div class="card">
          <h3>Assay strategy</h3>
          <p>
            Prioritise functional readouts (e.g., mitochondrial state, redox stress, cell-fate markers) and confirm in orthogonal
            assays to reduce artefacts early.
          </p>
        </div>
        <div class="card">
          <h3>Hit confirmation</h3>
          <p>
            Re-test, counterscreen, and validate mechanism-of-action signals before investing in chemistry optimisation.
          </p>
        </div>
        <div class="card">
          <h3>Optimisation path</h3>
          <p>
            Move from hit → lead with defined criteria: potency, selectivity, cellular activity, and a credible translational plan.
          </p>
        </div>
      </div>

      <hr class="hr" />

      <h2>Protocolised program development</h2>
      <p>
        A mitochondria-centric hypothesis is only useful if it translates into a program that can be executed. We therefore
        design programs as protocolised development packages: defined patient logic, measurable biomarkers, and milestone-driven
        experiments that connect mechanism to clinical signal.
      </p>

      <div class="grid-3">
        <div class="card">
          <h3>Program definition</h3>
          <p>Indication selection + mechanistic rationale + clear go/no-go criteria.</p>
        </div>
        <div class="card">
          <h3>Translational readouts</h3>
          <p>Biomarkers and functional endpoints aligned to the mitochondrial/metabolic state the program targets.</p>
        </div>
        <div class="card">
          <h3>Clinical discipline</h3>
          <p>Protocol design that prioritises measurement, patient stratification hypotheses, and early signal detection.</p>
        </div>
      </div>

      <hr class="hr" />

      <h2>Mechanistic targeting framework</h2>
      <p>
        The platform is designed to apply coordinated pressure across survival signalling, metabolic coupling, and immune context.
        Example target classes include:
      </p>

      <ul class="list">
        <li><strong>Bcl-2 modulation</strong> — influence apoptotic priming and survival dependency</li>
        <li><strong>MCT-1 modulation</strong> — disrupt lactate export and metabolic coupling</li>
        <li><strong>LDH modulation</strong> — reduce glycolytic dominance where relevant</li>
        <li><strong>PDK modulation</strong> — shift flux toward oxidative metabolism</li>
        <li><strong>AMPK / mTOR axis</strong> — recalibrate energy sensing and growth signalling</li>
        <li><strong>Acidosis / pH biology</strong> — reduce acid-mediated invasion and immune suppression</li>
        <li><strong>Immune engagement</strong> — design programs compatible with effective immune activity</li>
        <li><strong>Antimicrobial context (where relevant)</strong> — address microbial contributions to inflammatory signalling</li>
        <li><strong>Mitochondrial repair</strong> — restore bioenergetic integrity and signalling fidelity</li>
      </ul>

      <p style="color:var(--muted);margin-top:14px;">
        We communicate our science responsibly: programs are hypothesis-driven and milestone-gated, with claims anchored to
        measurable validation.
      </p>
    </div>
  </section>
</main>

<footer class="footer">
  <div class="container">© 2026 Mito Laboratories. All rights reserved.</div>
</footer>

<script src="script.js"></script>
</body>
</html>
